Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results

GLENWOOD, Ill., Jan. 25 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal first quarter of 2010 pre-market on Tuesday, February 2, 2010.

The company will host a conference call for investors on Tuesday, February 2, 2010, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-8631 (within the United States and Canada), or 480-629-9820 (international callers), or by visiting the "Investors" page on the company's website at  Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-406-7325 (within the United States and Canada), or 303-590-3030 (international callers), passcode 4205610#, which will be available through Tuesday, March 2, 2010.  The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the world's leading provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services.   For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.6 million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia, Mexico and other countries.  In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and diagnostic physics services and educational services to the medical physics community.

For the latest news releases and other corporate documents on Landauer Inc.,


SOURCE Landauer, Inc.



SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
2. Roche responds to announcement of IDEAL hepatitis C trial results
3. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
4. MannKind Addresses Pfizers Announcement Regarding Exubera
5. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
6. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
7. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
8. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
9. CDC Urges Pre-Teen Vaccination With New Public Service Announcements
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
Post Your Comments:
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)...  Six months of adjunctive metformin therapy does not improve ... to new research from T1D Exchange and funded ... beneficial effect on measures of obesity, including weight and BMI. ... Journal of the American Medical Association , are from the ... on overweight and obese adolescents with type 1 diabetes. ...
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday 27 Oct 2015, ... educate the personnel on spinal decompression therapy and offer his professional help. , ... The benefits come from creating negative intradiscal pressure which is conducive to retraction ...
(Date:12/1/2015)... ... 01, 2015 , ... World Patent Marketing , a vertically integrated ... allows for easier packing and organizing of items into one big, portable jar. , ... Cooper, CEO and Creative Director of World Patent Marketing and Desa Industries Inc ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an article ... a discrimination claim against the U.S. Department of Health and Human Services, claiming that ... (ACA) plans are breaking the clause in the law prohibiting the denial of coverage ...
(Date:12/1/2015)... Los Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... the United States, today announced that its iconic bottle has won top honors in ... drinks category. The Company also announced that it has been selected as a ...
Breaking Medicine News(10 mins):